MedTrace Logo

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

NCT06979284 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 772

Last updated 2025-05-18

No results posted yet for this study

Summary

The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascularization.

Conditions

  • Peripheral Arterial Disease(PAD)
  • Chronic Limb Threatening Ischemia
  • Intravascular Ultrasound
  • Major Adverse Limb Events
  • Restenosis

Interventions

PROCEDURE

IVUS-guided strategy

Percutaneous revascularization will be performed using intravascular ultrasound. The operators will follow instructions to modify arteries hardened by calcium and use IVUS to optimize the equipment (balloon and stents) used to unblock the artery.

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2030-07-31
Completion
2030-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979284 on ClinicalTrials.gov